FDA Inspection 847629 — GlaxoSmithKline LLC
The FDA completed an inspection of GlaxoSmithKline LLC on Aug 23, 2013 in King of Prussia, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 23, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- King of Prussia, PA (United States)
Additional details
Sponsor, Contract Research Organization